Abstract
The causes of amyotrophic lateral sclerosis (ALS), a devastating human neurodegenerative disease, are poorly understood, although the protein TDP-43 has been suggested to have a critical role in disease pathogenesis. Here we show that ataxin 2 (ATXN2), a polyglutamine (polyQ) protein mutated in spinocerebellar ataxia type 2, is a potent modifier of TDP-43 toxicity in animal and cellular models. ATXN2 and TDP-43 associate in a complex that depends on RNA. In spinal cord neurons of ALS patients, ATXN2 is abnormally localized; likewise, TDP-43 shows mislocalization in spinocerebellar ataxia type 2. To assess the involvement of ATXN2 in ALS, we analysed the length of the polyQ repeat in the ATXN2 gene in 915 ALS patients. We found that intermediate-length polyQ expansions (27–33 glutamines) in ATXN2 were significantly associated with ALS. These data establish ATXN2 as a relatively common ALS susceptibility gene. Furthermore, these findings indicate that the TDP-43–ATXN2 interaction may be a promising target for therapeutic intervention in ALS and other TDP-43 proteinopathies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cleveland, D. W. & Rothstein, J. D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Rev. Neurosci. 2, 806–819 (2001)
Valentine, J. S. & Hart, P. J. Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 100, 3617–3622 (2003)
Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130–133 (2006)
Pesiridis, G. S., Lee, V. M. & Trojanowski, J. Q. Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, R156–R162 (2009)
Lagier-Tourenne, C. & Cleveland, D. W. Rethinking ALS: the FUS about TDP-43. Cell 136, 1001–1004 (2009)
Winton, M. J. et al. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302–13309 (2008)
Cooper, A. A. et al. α-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science 313, 324–328 (2006)
Gitler, A. D. et al. α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nature Genet. 41, 308–315 (2009)
Orr, H. T. & Zoghbi, H. Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575–621 (2007)
Imbert, G. et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet. 14, 285–291 (1996)
Lorenzetti, D., Bohlega, S. & Zoghbi, H. Y. The expansion of the CAG repeat in ataxin-2 is a frequent cause of autosomal dominant spinocerebellar ataxia. Neurology 49, 1009–1013 (1997)
Pulst, S. M. et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet. 14, 269–276 (1996)
Sanpei, K. et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet. 14, 277–284 (1996)
Infante, J. et al. Spinocerebellar ataxia type 2 with levodopa-responsive parkinsonism culminating in motor neuron disease. Mov. Disord. 19, 848–852 (2004)
Nanetti, L. et al. Rare association of motor neuron disease and spinocerebellar ataxia type 2 (SCA2): a new case and review of the literature. J. Neurol. 256, 1926–1928 (2009)
Mangus, D. A., Amrani, N. & Jacobson, A. Pbp1p, a factor interacting with Saccharomyces cerevisiae poly(A)-binding protein, regulates polyadenylation. Mol. Cell. Biol. 18, 7383–7396 (1998)
Buchan, J. R., Muhlrad, D. & Parker, R. P bodies promote stress granule assembly in Saccharomyces cerevisiae. J. Cell Biol. 183, 441–455 (2008)
Al-Ramahi, I. et al. dAtaxin-2 mediates expanded Ataxin-1-induced neurodegeneration in a Drosophila model of SCA1. PLoS Genet. 3, e234 (2007)
Lessing, D. & Bonini, N. M. Polyglutamine genes interact to modulate the severity and progression of neurodegeneration in Drosophila. PLoS Biol. 6, e29 (2008)
Auluck, P. K., Chan, H. Y., Trojanowski, J. Q., Lee, V. M. & Bonini, N. M. Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson’s disease. Science 295, 865–868 (2002)
Warrick, J. M. et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nature Genet. 23, 425–428 (1999)
Johnson, B. S. et al. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J. Biol. Chem. 284, 20329–20339 (2009)
Buratti, E. & Baralle, F. E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 276, 36337–36343 (2001)
Huynh, D. P., Yang, H. T., Vakharia, H., Nguyen, D. & Pulst, S. M. Expansion of the polyQ repeat in ataxin-2 alters its Golgi localization, disrupts the Golgi complex and causes cell death. Hum. Mol. Genet. 12, 1485–1496 (2003)
Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N. & Goldberg, A. L. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell 14, 95–104 (2004)
Colombrita, C. et al. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 111, 1051–1061 (2009)
Nonhoff, U. et al. Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol. Biol. Cell 18, 1385–1396 (2007)
Freibaum, B. D., Chitta, R. K., High, A. A. & Taylor, J. P. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J. Proteome Res. 9, 1104–1120 (2010)
Jackson, M., Llado, J. & Rothstein, J. D. Therapeutic developments in the treatment of amyotrophic lateral sclerosis. Expert Opin. Investig. Drugs 11, 1343–1364 (2002)
Krobitsch, S. & Lindquist, S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl Acad. Sci. USA 97, 1589–1594 (2000)
Johnson, B. S., McCaffery, J. M., Lindquist, S. & Gitler, A. D. A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 105, 6439–6444 (2008)
Outeiro, T. F. & Lindquist, S. Yeast cells provide insight into α-synuclein biology and pathobiology. Science 302, 1772–1775 (2003)
Li, L. B., Yu, Z., Teng, X. & Bonini, N. M. RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453, 1107–1111 (2008)
Acknowledgements
This work was supported in part by a Pilot grant from the University of Pennsylvania Institute on Aging (A.D.G.), an NIH Director’s New Innovator Award 1DP2OD004417-01 (A.D.G.), 1R01NS065317-01 (A.D.G.), P01 AG-09215 (N.M.B.), AG-10124 (J.Q.T., V.M.V.D.) and AG-17586, (V.M.-Y.L., V.M.V.D.). A.D.G. is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts. A.S.C.-P. is supported by a Burroughs Wellcome Fund Career Award and NIH K08 AG-033101-01. N.M.B. is an Investigator of the Howard Hughes Medical Institute. U.R. has support from the Deutsche Heredo-Ataxie Gesellschaft (DHAG) and Autosomal Dominant Cerebellar Ataxia (ADCA) Vereniging Nederland, G.A. from the European Integrated Project on Spinocerebellar Ataxias (EuroSCA) and the Deutsche Forschungsgemeinschaft (DFG) (AU96/11-1). We acknowledge W. den Dunnen and E. Brunt for autopsy tissue and M. Babl for technical assistance. We thank J. Epstein, J. Shorter, A. Cashmore and members of the Gitler laboratory for comments on the manuscript and discussions. We are grateful for the dedication of the patients and their families and for their invaluable contributions to this research.
Author information
Authors and Affiliations
Contributions
N.M.B. and A.D.G. are co-senior authors. M.P.H., H.-J.K., A.S.C.-P., F.G., U.R., G.A., J.Q.T., V.M.-Y.L., V.M.V.D., N.M.B. and A.D.G. designed the experiments. A.C.E., H.-J.K., M.P.H., B.S.J., X.F., M.A., R.G., M.M.L., U.R. and A.D.G. performed the research. D.J. and P.J.G. provided the reagents. D.C. and V.M.V.D. collected the clinical data. A.S.C.-P., L.E. and L.M. assessed clinical characteristics. M.P.H., H.-J.K., A.S.C.-P., F.G., A.P., L.E., L.M., U.R., G.A., J.Q.T., V.M.-Y.L., V.M.V.D., N.M.B. and A.D.G. analysed and interpreted data. N.M.B. and A.D.G. wrote the paper with contributions from all authors.
Corresponding authors
Ethics declarations
Competing interests
[Competing Interests: A.D.G. is an inventor on patents and patent applications that have been licensed to FoldRx.]
Supplementary information
Supplementary Information
This file contains Supplementary Data, a Supplementary Discussion, additional References and Supplementary Figures 1-11 with legends. (PDF 990 kb)
Supplementary Table 1
This file contains Ataxin-2 polyQ lengths for ALS patients and control individuals and ages for control individuals. (XLS 35 kb)
Supplementary Table 2
This file contains the demographic and clinical characteristics of ALS patients and control individuals. (XLS 22 kb)
Rights and permissions
About this article
Cite this article
Elden, A., Kim, HJ., Hart, M. et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069–1075 (2010). https://doi.org/10.1038/nature09320
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nature09320
This article is cited by
-
Beyond C9orf72: repeat expansions and copy number variations as risk factors of amyotrophic lateral sclerosis across various populations
BMC Medical Genomics (2024)
-
Photoswitchable polyynes for multiplexed stimulated Raman scattering microscopy with reversible light control
Nature Communications (2024)
-
Assisting the analysis of insertions and deletions using regional allele frequencies
Functional & Integrative Genomics (2024)
-
Translating the ALS Genetic Revolution into Therapies: A Review
Current Treatment Options in Neurology (2024)
-
A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration
Nature Communications (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.